Table 1: Summary of Current Prostate Cancer Guidelines From Selected Organizations

Table 1:
Summary of Current Prostate Cancer Guidelines From Selected Organizations
ACP-ASIM	Physicians should describe potential benefits and known harms of screening, diagnosis and treatment; listen to the patient's concerns, then individualize the decision to screen.
ACS, AUA	Offer annual DRE and PSA screening, beginning at age 50, to men who have at least a 10-year life expectancy and to younger men at high risk.
CTFPHC and USPSTF	DRE and PSA tests are not recommended for the general population.
AAFP	No published standards or guidelines for low-risk patients.
AMA	Provide information regarding the risks and potential benefits of prostate screening.
ACP-ASIM: American College of Physicians-American Society of Internal Medicine ACS: American Cancer Society AUA: American Urological Association CTFPHC: Canadian Task Force on Preventive Health Care USPSTF: U.S. Preventive Services Task Force AAFP: American Academy of Family Physicians AMA: American Medical Association DRE: Digital Rectal Exam